Treatment Options for Heavy Menstrual Bleeding
The levonorgestrel-releasing intrauterine device (LNG-IUD) is the most effective treatment for heavy menstrual bleeding, reducing blood loss by 40-50% and inducing amenorrhea in many users. 1
First-Line Treatment Options
Hormonal Options
Levonorgestrel-releasing intrauterine device (LNG-IUD)
Combined hormonal contraceptives (CHCs)
- Effective for reducing heavy menstrual bleeding 3
- Available as pills, vaginal rings, or patches
- Moderate-quality evidence shows CHCs can increase successful treatment from 3% to 77% compared to placebo 3
- Less effective than LNG-IUD but still a viable option 3
- Consider higher estrogen content (30-35 μg ethinyl estradiol) for better control of breakthrough bleeding 1
Progestin-only options
- Oral progestins
- Injectable progestins (DMPA)
- Typical failure rate of 5-9% for pills 1
Non-hormonal Options
Tranexamic acid
NSAIDs (e.g., mefenamic acid, naproxen)
Treatment Algorithm
For Acute Heavy Bleeding
- Assess hemodynamic stability (orthostatic blood pressure and pulse) 4
- First-line: Medical management 4
- Tranexamic acid (oral or IV)
- High-dose combined hormonal contraceptives
- IV estrogen for severe cases
- Second-line: Surgical options (only if medical therapy fails or patient is clinically unstable) 4
For Chronic Heavy Bleeding
First-line: LNG-IUD 1
- Most effective option with minimal side effects
- Provides long-term management and contraception
Alternative first-line options:
- Combined hormonal contraceptives
- Tranexamic acid
- NSAIDs
Second-line: Surgical options
Special Considerations
Women with Bleeding Disorders
- LNG-IUD is particularly beneficial 1, 4
- Tranexamic acid is effective 4
- All hormonal methods can be used 5
Women with Cardiovascular Disease
- Avoid estrogen-containing contraceptives due to thromboembolism risk 1
- LNG-IUD is the safest option 1
Women with Thrombocytopenia
Long-term Outcomes
- In a 10-year follow-up study, only 29% of women with heavy menstrual bleeding required surgical intervention 7
- 43% of women had ceased all medical treatments after 10 years 7
- 43% were using LNG-IUD alone or in combination with other treatments 7
Common Pitfalls and Caveats
- Unexplained vaginal bleeding should be evaluated for underlying pathology before treatment 2
- Breakthrough bleeding is common when starting hormonal contraceptives and typically resolves within 2-3 cycles 1
- Estrogen-containing contraceptives should be avoided in women at high risk for thromboembolic events 1
- No antibiotic prophylaxis is needed for LNG-IUD insertion 1
- Vasovagal reactions occur in approximately 5% of patients during IUD insertion 1
Remember that medical management is the first-line approach for heavy menstrual bleeding, with surgical options reserved for those who don't respond to medical therapy.